Arphra
live
S&P 5007,511.35-0.57%
NASDAQ29,968.13-1.89%
DOW51,999.67+0.64%
VIX16.35-0.37%
US10Y4.43-0.94%
EUR/USD1.1506-0.93%
GOLD4,300.5-1.26%
WTI75.22-0.90%
BTC64,442.01-1.87%
S&P 5007,511.35-0.57%
NASDAQ29,968.13-1.89%
DOW51,999.67+0.64%
VIX16.35-0.37%
US10Y4.43-0.94%
EUR/USD1.1506-0.93%
GOLD4,300.5-1.26%
WTI75.22-0.90%
BTC64,442.01-1.87%

0O5H.IL

Elekta AB (publ)
HealthcareMedical - Instruments & SuppliesSESEKPeers →via fmp_bulkCountry macro →
$48.66
Jun 18, 2026
AI Brief
Market cap
$17.82B
52w range
P / E
EPS · FY 2026
$-1.35
Volume
Revenue · FY 2026
$16.72B

Explain this page

Arphra AI
Business description
· company · SEC profile

Elekta AB (publ)

Elekta AB (publ) is a global medical technology firm specializing in clinical solutions for managing cancer and various brain disorders. Its diverse product portfolio includes Versa HD, developed for brain metastases treatment; Elekta Unity, an innovative MR-Linac technology; Elekta Harmony, a sophisticated linear accelerator; Elekta Infinity, addressing a wide range of radiotherapy requirements from simple to complex; and Elekta Synergy, a digital accelerator for advanced image-guided radiation therapy. The company also offers integrated treatment management, automated quality assurance systems, and advanced hardware and software for precise motion management. Additionally, Elekta provides MOSAIQ Plaza for coordinating multidisciplinary cancer care; Elekta Axis Cloud, a managed hosting service; Elekta Studio, an image-guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, an intelligent tool for streamlining repetitive tasks; the Venezia applicator, enabling radiation oncologists to treat locally advanced cervical cancer; the Elekta Flexitron afterloader, ensuring precise execution throughout the brachytherapy workflow; and Geneva, another specialized applicator for cervical cancer treatment. For specialized radiation and neurosurgery, Elekta features the Leksell Gamma Knife Icon for personalized radiation treatment; the Leksell Gamma Knife Perfexion, a key tool for neurosurgeons; and the Leksell Gamma Knife Lightning, designed for accelerated radiosurgery. Its neurosurgery offerings also encompass the Leksell Vantage Stereotactic System for intracranial neurosurgery and the Leksell Stereotactic System for minimally invasive stereotactic procedures. Established in 1972, Elekta maintains its headquarters in Stockholm, Sweden.

Founded
IPO
Oct 07, 2009
Employees
4,700
HQ
Stockholm
CEO
Gustaf Salford
CFO
Exchange
IOB
Fiscal year
Identifiers
· company_identifiers
CIK
CUSIP
ISINSE0000163628
FIGI
LEI
Cross-listings
· companies · ISIN
  • EKTA-B.STPrimaryNasdaq StockholmseSEK$1.99B
  • EKTAYOTCUSD$1.93B
  • EKTAFOTCUSD$1.85B
  • 0O5H.ILIOBSEK
The global universe keeps only the primary listing; the other venues for this security are shown here.